Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A3 | P47895 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.47 |
| ▸ | TYR | P14679 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.38 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.37 |
| ▸ | TUBB | P07437 | 1/20 | 0.37 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.37 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.37 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.37 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.37 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.37 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.37 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.37 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.37 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.37 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.37 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.37 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10804430 | 0.82 | CYP2A6 (0.67) | ALDH1A3ALDH1A1CYP2A6TYRTSHR | |
| SCHEMBL2081426 | 0.80 | HSD17B10 (0.64) | ALDH1A3ALDH1A1CYP2A6TYRTSHR | |
| Cuminaldehyde SCHEMBL10581976 | 0.80 | TYR (0.76) | ALDH1A3ALDH1A1CYP2A6TYRTSHR | |
| Anisaldehyde SCHEMBL598535 | 0.80 | ALDH1A1 (0.76) | ALDH1A3ALDH1A1CYP2A6TYRTSHR | |
| 4-Hydroxybenzaldehyde SCHEMBL8727208 | 0.80 | ALDH5A1 (0.64) | ALDH1A3ALDH1A1CYP2A6TYRALDH5A1 | |
| SCHEMBL6034 | 0.80 | — | — | |
| SCHEMBL17231886 | 0.80 | CYP2A6 (0.52) | ALDH1A3ALDH1A1CYP2A6TYRCYP2A13 | |
| SCHEMBL569625 | 0.79 | LMNA (0.43) | ALDH1A3ALDH1A1CYP2A6TYRMAOA | |
| Benzaldehyde SCHEMBL432383 | 0.79 | ALDH1A1 (0.61) | ALDH1A3ALDH1A1CYP2A6TYRTSHR | |
| Acetaldehyde SCHEMBL21722112 | 0.78 | CYP2A6 (0.52) | ALDH1A3ALDH1A1CYP2A6TYRCYP2A13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132295-A1 | COMPOUND, COMPOSITION, SURFACE TREATMENT AGENT, METHOD FOR MANUFACTURING ARTICLE, AND ARTICLE | AGC Inc. (JP) | 2026-05-14 | — | — | US | disclosed |
| US-20220411449-A1 | Method for Preparing Heteroleptic Triarylbismuthanes and Compounds Produced by the Same | UNIVERSITY OF HAWAII | 2022-12-29 | — | — | US | disclosed |
| WO-2022254901-A1 | NOVEL ORGANOSILICON COMPOUND, NOVEL CROSSLINKING AGENT, CURABLE COMPOSITION, PREPREG, LAMINATE, METAL-CLAD LAMINATED BOARD, AND WIRING BOARD | ＡＧＣ株式会社 | 2022-12-08 | — | — | WO | disclosed |
| WO-2022254902-A1 | NOVEL ORGANOSILICON COMPOUND, NOVEL CROSSLINKING AGENT, CURABLE COMPOSITION, PREPREG, MULTILAYER BODY, METAL-CLAD LAMINATE AND WIRING BOARD | ＡＧＣ株式会社 | 2022-12-08 | — | — | WO | disclosed |
| CN-110092734-B | Tandem synthesis method of 2- (phenylmethylene) malononitrile or derivatives thereof | 华侨大学 | 2021-12-31 | — | — | CN | disclosed |
| WO-2021097159-A1 | METHOD FOR PREPARING HETEROLEPTIC TRIARYLBISMUTHANES AND COMPOUNDS PRODUCED BY THE SAME | UNIVERSITY OF HAWAII (US) | 2021-05-20 | — | — | WO | disclosed |
| CN-110092734-A | A kind of 2-(phenylmethylene) malononitrile or derivatives thereof series connection synthetic method | 华侨大学 | 2019-08-06 | — | — | CN | disclosed |
| CN-103130812-B | Indolo[3,2,1-jk]carbazole derivative, preparation method and application | UNIV EAST CHINA NORMAL | 2014-12-24 | — | — | CN | disclosed |
| US-8859615-B2 | Compounds, compositions and methods for reducing toxicity and treating or preventing diseases | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2014-10-14 | — | — | US | disclosed |
| CN-102659969-B | Functional high molecular sensing material with potassium ion selectivity based on click chemistry and application thereof | NANJING UNIVERSITY OF TECHNOLOGY | 2013-10-30 | — | — | CN | disclosed |
| CN-1082508-C | Heterocyclic azahexane derivatives with antiviral activity | NOVARTIS AG (CH) | 2002-04-10 | — | — | CN | disclosed |
| CN-1319587-A | Heterocyclic azahexane derivatives with antiviral activity | NOVARTIS AG (CH) | 2001-10-31 | — | — | CN | disclosed |
| US-6284756-B1 | ANTICOAGULANT | ELI LILLY AND COMPANY | 2001-09-04 | — | — | US | disclosed |
| EP-1027051-A4 | ANTITHROMBOTIC AGENTS | LILLY CO ELI (US) | 2001-03-07 | — | — | EP | disclosed |
| EP-1027051-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 2000-08-16 | — | — | EP | disclosed |
| EP-0993300-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 2000-04-19 | — | — | EP | disclosed |
| CN-1216539-A | Heterocyclic azahexane derivatives with antiviral activity | NOVARTIS AG (CH) | 1999-05-12 | — | — | CN | disclosed |
| WO-1998048798-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1998-11-05 | — | — | WO | disclosed |
| WO-1998048804-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1998-11-05 | — | — | WO | disclosed |
| US-4699698-A | Preparation of benzoic acid ortho-esters and novel compounds of this type | BASF AKTIENGESELLSCHAFT (DE) | 1987-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132295-A1 | COMPOUND, COMPOSITION, SURFACE TREATMENT AGENT, METHOD FOR MANUFACTURING ARTICLE, AND ARTICLE | MSR1, SEM1, ASH2L | ALDH1A3 4059/4885ALDH1A1 2834/4885CYP2A6 3611/4885 |
| US-20220411449-A1 | Method for Preparing Heteroleptic Triarylbismuthanes and Compounds Produced by the Same | COASY, HAGH, MRM1 | ALDH1A3 1155/4885ALDH1A1 1762/4885CYP2A6 611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.